November 14, 2026
$RichWire Markets and money, explained simply
LIVE
Credo Technology Shares Fall Sharply Following September Earnings Report Artificial Intelligence Dominates Market Focus Once Again Nvidia Shares Slide as CEO Jensen Huang Resigns Following Scandal Embraer Maintains Buy Rating Following Third-Quarter Performance Anthropic Targets $1.4 Trillion Valuation in Upcoming Nasdaq Debut Lowe's Positioned for Growth Amid Expanding Home Remodeling Budgets Examining OMS Energy Technologies: Balance Sheet Strength and Growth Prospects NextEra Energy Emerges as Value Opportunity Amid Utility Sector Pullback Carlsmed and the Upcoming Reimbursement Reset Evaluating the Risk-Reward Profile of BlackRock MuniHoldings California Quality Fund BorgWarner Shifts Propulsion Expertise Toward Data Centers and Industrial Power Jenoptik Reports Double-Digit Revenue Growth Amid Semiconductor Surge Credo Technology Shares Fall Sharply Following September Earnings Report Artificial Intelligence Dominates Market Focus Once Again Nvidia Shares Slide as CEO Jensen Huang Resigns Following Scandal Embraer Maintains Buy Rating Following Third-Quarter Performance Anthropic Targets $1.4 Trillion Valuation in Upcoming Nasdaq Debut Lowe's Positioned for Growth Amid Expanding Home Remodeling Budgets Examining OMS Energy Technologies: Balance Sheet Strength and Growth Prospects NextEra Energy Emerges as Value Opportunity Amid Utility Sector Pullback Carlsmed and the Upcoming Reimbursement Reset Evaluating the Risk-Reward Profile of BlackRock MuniHoldings California Quality Fund BorgWarner Shifts Propulsion Expertise Toward Data Centers and Industrial Power Jenoptik Reports Double-Digit Revenue Growth Amid Semiconductor Surge
Home

Topic: Nektar Therapeutics

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.